Goldman Sachs’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$92.2K Buy
207,646
+61,341
+42% +$27.2K ﹤0.01% 4897
2025
Q1
$82.8K Sell
146,305
-51,099
-26% -$28.9K ﹤0.01% 4856
2024
Q4
$417K Buy
197,404
+21,980
+13% +$46.4K ﹤0.01% 4380
2024
Q3
$472K Buy
175,424
+97,590
+125% +$263K ﹤0.01% 4140
2024
Q2
$222K Buy
77,834
+37,904
+95% +$108K ﹤0.01% 4321
2024
Q1
$169K Sell
39,930
-344
-0.9% -$1.46K ﹤0.01% 4370
2023
Q4
$215K Buy
40,274
+9,893
+33% +$52.9K ﹤0.01% 4298
2023
Q3
$131K Sell
30,381
-16,645
-35% -$71.6K ﹤0.01% 4343
2023
Q2
$258K Buy
47,026
+9,936
+27% +$54.5K ﹤0.01% 4301
2023
Q1
$156K Buy
37,090
+24,336
+191% +$102K ﹤0.01% 4588
2022
Q4
$35.3K Sell
12,754
-24,381
-66% -$67.5K ﹤0.01% 4831
2022
Q3
$95K Sell
37,135
-25,883
-41% -$66.2K ﹤0.01% 4930
2022
Q2
$227K Sell
63,018
-30,718
-33% -$111K ﹤0.01% 4843
2022
Q1
$583K Sell
93,736
-3,862
-4% -$24K ﹤0.01% 4468
2021
Q4
$688K Sell
97,598
-3,003
-3% -$21.2K ﹤0.01% 4297
2021
Q3
$702K Sell
100,601
-123,175
-55% -$860K ﹤0.01% 4196
2021
Q2
$1.86M Buy
223,776
+135,442
+153% +$1.13M ﹤0.01% 3571
2021
Q1
$483K Sell
88,334
-21,025
-19% -$115K ﹤0.01% 4386
2020
Q4
$470K Sell
109,359
-1,560
-1% -$6.71K ﹤0.01% 3853
2020
Q3
$334K Buy
110,919
+69,680
+169% +$210K ﹤0.01% 3847
2020
Q2
$128K Buy
41,239
+30,211
+274% +$93.8K ﹤0.01% 4114
2020
Q1
$24K Sell
11,028
-615
-5% -$1.34K ﹤0.01% 4341
2019
Q4
$36K Buy
11,643
+2
+0% +$6 ﹤0.01% 4226
2019
Q3
$36K Sell
11,641
-268,318
-96% -$830K ﹤0.01% 4154
2019
Q2
$560K Buy
279,959
+266,430
+1,969% +$533K ﹤0.01% 3475
2019
Q1
$58K Buy
+13,529
New +$58K ﹤0.01% 4071
2018
Q4
Sell
-26,110
Closed -$137K 4155
2018
Q3
$137K Sell
26,110
-44
-0.2% -$231 ﹤0.01% 3889
2018
Q2
$140K Sell
26,154
-95,693
-79% -$512K ﹤0.01% 3955
2018
Q1
$609K Buy
121,847
+99,976
+457% +$500K ﹤0.01% 3404
2017
Q4
$72K Sell
21,871
-13
-0.1% -$43 ﹤0.01% 4003
2017
Q3
$82K Sell
21,884
-10,544
-33% -$39.5K ﹤0.01% 4066
2017
Q2
$83K Buy
32,428
+6,774
+26% +$17.3K ﹤0.01% 4175
2017
Q1
$67K Sell
25,654
-5,825
-19% -$15.2K ﹤0.01% 4182
2016
Q4
$96K Buy
31,479
+16,014
+104% +$48.8K ﹤0.01% 4112
2016
Q3
$42K Sell
15,465
-16,231
-51% -$44.1K ﹤0.01% 4343
2016
Q2
$91K Sell
31,696
-25,677
-45% -$73.7K ﹤0.01% 4149
2016
Q1
$173K Buy
57,373
+45,884
+399% +$138K ﹤0.01% 3833
2015
Q4
$40K Sell
11,489
-182,178
-94% -$634K ﹤0.01% 4242
2015
Q3
$732K Buy
193,667
+175,459
+964% +$663K ﹤0.01% 3083
2015
Q2
$104K Sell
18,208
-1,487
-8% -$8.49K ﹤0.01% 4285
2015
Q1
$115K Buy
19,695
+3,011
+18% +$17.6K ﹤0.01% 4113
2014
Q4
$95K Sell
16,684
-21,885
-57% -$125K ﹤0.01% 4253
2014
Q3
$158K Buy
38,569
+5,364
+16% +$22K ﹤0.01% 4074
2014
Q2
$151K Buy
+33,205
New +$151K ﹤0.01% 4092